Guardion Health Sciences, Inc. Stock

Equities

GHSI

US40145Q5009

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
8.05 USD -0.25% Intraday chart for Guardion Health Sciences, Inc. -0.62% +50.75%
Sales 2024 * 13.45M Sales 2025 * 14.8M Capitalization 10.34M
Net income 2024 * -3M Net income 2025 * -3M EV / Sales 2024 * 0.77 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.7 x
P/E ratio 2024 *
-3.35 x
P/E ratio 2025 *
-7.89 x
Employees 9
Yield 2024 *
-
Yield 2025 *
-
Free-Float 77.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.25%
1 week-0.62%
Current month-10.80%
1 month-9.75%
3 months+54.21%
6 months+23.28%
Current year+50.75%
More quotes
1 week
7.75
Extreme 7.75
8.19
1 month
7.45
Extreme 7.4501
9.20
Current year
5.01
Extreme 5.0102
10.75
1 year
5.01
Extreme 5.0102
10.75
3 years
4.66
Extreme 4.655
109.00
5 years
4.66
Extreme 4.655
915.00
10 years
4.66
Extreme 4.655
1 200.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-06-18
Chairman 72 15-06-29
Comptroller/Controller/Auditor - 23-07-24
Members of the board TitleAgeSince
Chairman 72 15-06-29
Director/Board Member 60 15-05-31
Director/Board Member 71 19-04-08
More insiders
Date Price Change Volume
24-04-18 8.05 -0.25% 4,090
24-04-17 8.07 +2.80% 2,250
24-04-16 7.85 -0.51% 3,285
24-04-15 7.89 -0.13% 4,360
24-04-12 7.9 -2.47% 3,092

Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT

More quotes
Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplements for bone health and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel flavored calcium chews constitute the main product category. It also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The Company's GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
8.05
Average target price
-
Consensus